Design of dual-acting thromboxane antagonist-synthase inhibitors by a mutual prodrug approach

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 3, 1996, Pages 273-278

  Brown, G R ^a   Clarke, D S ^a   Faull, A W ^a   Foubister, A J ^a   Smithers, M J ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; ENZYME INHIBITOR; PRODRUG; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ARTICLE; DOG; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; ENZYME INHIBITION; THROMBOCYTE AGGREGATION;

EID: 0030040782     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00004-2     Document Type: Article

References (11)

1. Gresele, P.; Deckmyn, H.; Nenci, G.G.; Vermylen, J. Trends Pharmacol. Sci. 1991, 12, 158-163.
2. Collington, E.W.; Finch, H. Ann. Rep. Med. Chem., Bristol, J.A. Ed., Academic Press Inc, San Diego, 1990, 25, 99-108.
3. Patscheke, H. Blut 1990, 60, 261-268.
4. Brewster, A.G.; Brown, G.R.; Foubister, A.J.; Jessup, R.; Smithers, M.J. Prostaglandins, 1988, 36, 173-178.
5. Faull, A.W.; Brewster, A.G.; Brown, G.R.; Smithers, M.J.; Jackson, R. J. Med. Chem. 1995, 38, 686-694.
6. Jessup, C. L.; Jessup, R.; Wayne, M. J. Pharm. Pharmacol. 1986, 38, 754-757.
7. Carey, F.; Fisher, R.W.; Haworth, D. Biochem. Soc. Trans. 1982, 10, 239-240.
8. Krogsgaard-Larsen, P.; Bundgaard, H. A Textbook of Drug Design and Development, Harwood Academic Publishers, Philadelphia, 1991, p 153.
9. Greene, T.W.; Wuts, P.G.M. Protective Groups in Organic Synthesis, John Wiley and Sons, New York, 1990, p 162.
10. Krogsgaard-Larsen, P.; Bundgaard, H. A Textbook of Drug Design and Development, Harwood Academic Publishers, Philadelphia, 1991, p156.
11. Fuller, E.J. J. Am. Chem. Soc. 1963, 85, 1777-1780.